Coronary Artery Disease
Conditions
Keywords
coronary artery bypass graft, midazolam, propofol
Brief summary
Propofol and midazolam are used frequently as sedating agents among patients who undergo coronary artery bypass graft surgery but no study in Pakistan has been done to compare their effectiveness aiming early extubation.
Detailed description
Propofol is an intra lipid and alkali phenol chemically it is unrelated to sedative agents or anaesthetic. Midazolam is a banzodiazepen. Most of its properties are similar to diazepam. It is a common practice to use sedatives to provide comfort and decrease ventilator-asynchrony in critically ill patients that may require prolonged invasive mechanical ventilation. The other reason to employ sedatives is to reduce the anxiety associated with the inaviseve procedures routinely conducted in the ICU.
Interventions
Midazolam infusion will be given after the surgery as 0.25 mg/kg/min.
Sponsors
Study design
Masking description
Open label
Intervention model description
Radomized Controlled Trial
Eligibility
Inclusion criteria
* Patients of American Society of Anesthesiologists (ASA) III who were selected for coronary artery bypass graft surgery.
Exclusion criteria
* History of any psychiatric disease. * Using antidepressants * Alcohol abusers * Obese * Pregnant women
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Duration of post-surgery sedation | Time in minutes calculated from end of surgery to the time of awakening up to 24 hours in both study groups | Duration of post-surgery sedation following cardiac surgery |
| Time taken to post-surgery extubation | Time taken in minutes from the end of the cardiac surgery to post-surgery extubation up to 1 week duration in both study groups | Time taken from the end of cardiac surgery to post-surgery extubation |
Countries
Pakistan